# Evaluation of Ambulatory Monitoring of Patients After High-risk Acute Coronary Syndrome Using Two Different Systems: Biomonitor-2 and Kardia Mobile

> **NCT03940066** · NA · COMPLETED · sponsor: **Fundación EPIC** · enrollment: 169 (actual)

## Conditions studied

- Atrial Fibrillation
- Syncope
- Tachycardia
- Arrhythmias, Cardiac
- Heart Diseases

## Interventions

- **DEVICE:** Biomonitor-2 and Kardia mobile
- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT03940066
- **Lead sponsor:** Fundación EPIC
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-12
- **Primary completion:** 2024-04-08
- **Final completion:** 2024-06-01
- **Target enrollment:** 169 (ACTUAL)
- **Last updated:** 2025-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03940066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03940066, "Evaluation of Ambulatory Monitoring of Patients After High-risk Acute Coronary Syndrome Using Two Different Systems: Biomonitor-2 and Kardia Mobile". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03940066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*